Scrip
Will combining GSK and Pfizer HIV businesses boost new therapies?
22 April 2009
Katie McQue
Please Login to read the full article.
22 April 2009
Katie McQue
In an effort to become the market leader for HIV, GlaxoSmithKline and Pfizer have merged their antiretroviral portfolios to create a so-far unnamed London-based speciality company led by GSK's Dr Dominique Limet, with 11 marketed products and another six in the clinical pipeline.
The...
Please Login to read the full article.
RELATED CONTENT
NEWS
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
- UNITAID: ViiV could signal others if it joins patent pool
- AIDS patent pool set to move forward amid concern over delays
- Mergers and acquisitions repositioning multinationals at the helm in India
COMMENT
Other Informa Comment
FEATURES
- Face to Face with Sandoz's "growth guy" Jeff George
- Recipharm sees opportunity to ride wave of CDMO consolidation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
